Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
BIN1 in cancer: biomarker and therapeutic target.
Chen SY, Cao JL, Li KP, Wan S, Yang L. Chen SY, et al. J Cancer Res Clin Oncol. 2023 Aug;149(10):7933-7944. doi: 10.1007/s00432-023-04673-7. Epub 2023 Mar 9. J Cancer Res Clin Oncol. 2023. PMID: 36890396 Review.
PURPOSE: Because BIN1 is commonly expressed in terminally differentiated normal tissues and is usually undetectable in refractory or metastatic cancer tissues, this differential expression has led us to focus on human cancers associated with BIN1. In this review, we discuss the p …
PURPOSE: Because BIN1 is commonly expressed in terminally differentiated normal tissues and is usually undetectable in refractory or metasta …
Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma.
Deng R, Li J, Zhao H, Zou Z, Man J, Cao J, Yang L. Deng R, et al. J Clin Lab Anal. 2021 Nov;35(11):e24022. doi: 10.1002/jcla.24022. Epub 2021 Oct 4. J Clin Lab Anal. 2021. PMID: 34606125 Free PMC article.
BACKGROUND: Immunotherapeutic approaches have recently emerged as effective treatment regimens against various types of cancer. However, the immune-mediated mechanisms surrounding papillary renal cell carcinoma (pRCC) remain unclear. ...
BACKGROUND: Immunotherapeutic approaches have recently emerged as effective treatment regimens against various types of cancer. However, the …